Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 79

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 10
Chunk 79
---
uant to the Amendments, no other fees, consideration or other amounts
are due to the Seller or EUDA upon the Maturity Date.

  51  

Debt
Obligations and Settlement Agreements with Fook Meng Chan

On
November 17, 2022, the Company issued to Shine Link Limited (“ Shine Link”), a company owned by Fook Meng Chan, a current
shareholder, an interest-free convertible promissory note in the aggregate principal amount of $119,0000 (“ Shine Link Note”).
Pursuant to the Shine Link Note, on November 17, 2023, the maturity date, Shine Link would have the right to convert the unpaid principal
amount of the Shine Link Note into ordinary shares of the Company based on the five day volume weighted average price of the Company’s
ordinary shares immediately preceding to the maturity date. At the May Board Meeting, the Board approved and authorized execution of
a Settlement Agreement with Shine Link (the “ Shine Link Settlement Agreement”) pursuant to which the Company agreed to issue
to Shine Link 119,000 restricted ordinary shares of the Company in full satisfaction of obligations under the Shine Link Note. On May
16, 2023, the Company issued to Shine Link an aggregate of 119,000 restricted ordinary shares pursuant to the Shine Link Settlement Agreement.

On
November 17, 2022, the Company issued to Menora Capital Pte Ltd (“ Menora”), a company owned by Fook Meng Chan, a current
shareholder, an interest-free convertible promissory note in the aggregate principal amount of $87,500 (“ Menora Note”). Pursuant
to the Menora Note, on November 17, 2023, the maturity date, Menora would have the right to convert the unpaid principal amount of the
Menora Note into ordinary shares of the Company based on the five day volume weighted average price of the Company’s ordinary shares
immediately preceding to the maturity date. At the May Board Meeting, the Board approved and authorized execution of a Settlement Agreement
with Menora (the “ Menora Settlement Agreement”) pursuant to which the Company agreed to issue to Menora 87,500 restricted
ordinary shares of the Company in full satisfaction of all obligations under the Menora Note. On May 16, 2023, the Company issued to
Menora an aggregate of 87,500 restricted ordinary shares pursuant to the Menora Settlement Agreement.

Private
Placements

Between
May and August